- Home
- NAMS vs BOBS Comparison
NAMS vs BOBS Comparison
Compare NAMS & BOBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NAMS | BOBS |
|---|---|---|
| Founded | 2019 | 1991 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 2.4B |
| IPO Year | 2022 | 2026 |
Fundamental Metrics
Financial Performance| Metric | NAMS | BOBS |
|---|---|---|
| Price | $20.60 | $21.41 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 13 |
| Target Price | ★ $50.22 | $23.15 |
| AVG Volume (30 Days) | ★ 1.6M | 1.0M |
| Earning Date | 11-04-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 32.81 | N/A |
| EPS | N/A | ★ 0.76 |
| Revenue | ★ $22,503,000.00 | N/A |
| Revenue This Year | $91.66 | $10.79 |
| Revenue Next Year | $62.38 | $7.22 |
| P/E Ratio | ★ N/A | $27.92 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $17.90 | $9.74 |
| 52 Week High | $42.21 | $23.11 |
Technical Indicators
Market Signals| Indicator | NAMS | BOBS |
|---|---|---|
| Relative Strength Index (RSI) | 49.33 | 83.50 |
| Support Level | $19.36 | $11.80 |
| Resistance Level | $22.28 | $23.11 |
| Average True Range (ATR) | 1.38 | 0.99 |
| MACD | 0.08 | 0.55 |
| Stochastic Oscillator | 60.55 | 95.19 |
Price Performance
Historical ComparisonAbout NAMS NewAmsterdam Pharma Company N.V.
NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments. The Company has one reportable segment, which comprises the discovery, development, and commercialization of transformative therapies for cardio-metabolic diseases.
About BOBS Bob's Discount Furniture Inc. Common Stock
Bobs Discount Furniture Inc operates as a furniture retailer offering a wide variety of merchandise assortments across several categories, including upholstery, case goods, bedding, and other. The company generates the majority of its revenue from the sale of its products through its retail stores.